As Shoppers Drug Mart Shops Around for Weed, What Should Cannabis Investors Do?

Tiray Canada Ltd. has just joined Aphria Inc. (TSX:APH) and MedReleaf Corp. (TSX:LEAF) as potential suppliers to Loblaw Companies Ltd.’s (TSX:L) subsidiary Shopper’s Drug Mart. What does this mean for cannabis investors?

With the Canadian cannabis landscape constantly changing on what seems to be a daily basis, keeping up with the stream of news regarding acquisitions, partnerships, production agreements, financing arrangements, and regulations can be very hard to do.

This past week, Shoppers Drug Mart, a subsidiary of Loblaw Companies Ltd. (TSX: L), signed a medical cannabis supply agreement with Tilray Canada Ltd., a medical marijuana producer based in British Columbia. The deal is the third of its kind for the Canadian pharmacy chain, with Shoppers already signing supply deals with both Aphria Inc. (TSX:APH) and MedReleaf Corp. (TSX:LEAF) last month.

Aphria was the first company which was able to sign on with Shoppers, and as CEO Vic Neufeld pointed out, Aphria will be the “first and primary” supplier of medical marijuana for Shoppers, noting supply minimums and other contractual volume-related stipulations have been agreed to in order for Shoppers to maintain exclusivity with Aphria.

While the Tilray announcement was a little sparser on the details, it represented an interesting strategic move by Shoppers in that pharmacy chains across the country appear to be scrambling to sort out supply prior to legalization in the coming months. Since medical marijuana is currently legal, the timeline for Loblaw’s (Shopper’s) Health Canada permit to be approved remains uncertain, although industry experts are hoping for regulatory changes sometime before legalization.

Loblaw originally applied for an application to dispense medical marijuana in 2016 and remains optimistic that pharmacies will officially be able to dispense medical marijuana in accordance with the provincial regulations relating to how the green drug will be retailed.

Bottom line

The rise in the number of supply deals between pharmacies and cannabis producers should not come as a surprise to investors; it would be imprudent for pharmacies to fail to put a plan in place should their applications be approved to sell pot.

That said, the recent valuation increases many firms have seen of late relating to these deals may be overdone, considering the fact that provincial governments will be investing millions in building independent cannabis stores to regulate the distribution of marijuana and keep cannabis out of the hands of minors, resulting in potential pushback from government officials on private retail in provinces such as Ontario, Quebec, and B.C., which have very strict alcohol retail regulations currently. The fact also remains that the Health Canada permit has not yet been approved, meaning the cart may be coming before the horse.

Stay Foolish, my friends.

Fool contributor Chris MacDonald has no position in any stocks mentioned in this article.

More on Top TSX Stocks

man in business suit pulls a piece out of wobbly wooden tower
Dividend Stocks

Overlooked Canadian Stocks Worth a Closer Look

Explore overlooked Canadian stocks North West Company and West Fraser, with essential retail demand and potential housing recovery upside.

Read more »

Oil industry worker works in oilfield
Energy Stocks

Canadian Natural Resources Has Raised Its Dividend for 26 Straight Years: Here’s Why It Stands Out

Canadian Natural Resources has raised its dividend for 26 straight years. Explore the assets and cash flow supporting its growing…

Read more »

Start line on the highway
Dividend Stocks

2 Simple Canadian Stocks to Buy With $1,000

Looking for Canadian stocks to buy with $1,000? Explore Enbridge and Scotiabank for dividend income and a straightforward long-term starting…

Read more »

up arrow on wooden blocks
Dividend Stocks

Standout Canadian Blue-Chip Stocks to Own in 2027

Explore Canadian blue-chip stocks for 2027, with Canadian National, Fortis and Manulife offering distinct paths to earnings growth and dividend…

Read more »

hiker with backpack in the mountains
Dividend Stocks

Retirement Income: Top Canadian Stocks That Keep Paying Out

Explore top Canadian stocks that keep paying out, with Enbridge, BMO and Granite REIT offering dividend income and monthly distributions

Read more »

3 colorful arrows racing straight up on a black background.
Energy Stocks

Enbridge’s $38 Billion Backlog Is Why This Dividend Stock Remains a Strong Hold

Enbridge’s $38 billion backlog supports its growth outlook. See why this dividend stock remains a strong hold for investors seeking…

Read more »

ETF is short for exchange traded fund, a popular investment choice for Canadians
Dividend Stocks

2 Top TSX ETFs to Buy and Hold in a TFSA Forever

Looking for top TSX ETFs for your TFSA? Explore how VFV and VDY combine U.S. stock exposure and Canadian dividends…

Read more »

A Canada Pension Plan Statement of Contributions with a 100 dollar banknote and dollar coins.
Dividend Stocks

Retiring in Canada: Create $750/Month in Dividend Income to Supplement CPP

Retiring soon? See how Scotiabank, Enbridge and XEI can generate $750 a month in dividend income to supplement your CPP…

Read more »